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ABSTRACT 
Cranial vault haemangiomas are benign vascular lesions having capillaries, venous and cavernous channels. 
Histopathologically, these are almost like soft tissue haemangiomas. These are slow growing tumors and very rarely bleed. 
Cranial vault is uncommon site for the occurrence as compared to the vertebral. Cross sectional imaging like Computerized 
Tomography (CT) and Magnetic Resonance Imaging (MRI) play an important role in delineation of the vault pathologies. We 
present a 38-years old male who presented with slow growing swelling over the frontal bone without any neurological 
symptoms. CT and MRI imaging clinched the diagnosis which was confirmed subsequently by histopathological examination.  
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alvarial haemangioma are like common soft tissue 
haemangiomas with slow growing tendencies. 
These frequently occur at vertebral and facial 
locations but a few are found in calvarium. 1% cases are in 
multiple [1]. The outer table is affected by the lytic lesion 
but can affect the whole vault thickness if giant in size as 
in our case. These give the appearance of multiple 
disorganized veins or vascular spaces. 
CASE REPORT 
38-years old male had a slow growing swelling on the 
right frontal bone over two years. It was very small in the 
beginning but the size increased without much of the 
complaints. Now, he had vague pain in the head especially 
at the site of swelling. There was no history of seizures or 
trauma. On examination, the individual was of average 
built with unremarkable systemic examination. Locally 
superficial skin over the swelling was of normal coloration 
and there was no break in the surface. All the blood and 
biochemical parameters were within normal limits.  
 
Figure 1 - Skull X-ray lateral view showing soft tissue 
swelling at frontoparietal region (black star) and causing 
destruction of the underlying bone (horizontal black arrow). 
Transition zone is well demarcated (vertical white arrow). 
Plain X-ray has shown the frontal soft tissue mass with 
destruction of the underlying table (Figure 1). Patient 
underwent CT and MRI examination and the extent of the 
lesion was delineated. NCCT and CECT brain has shown 
the expansile mass in the right frontal region extending  
C 
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Figure 2 – CT Head 2a- Axial section NCCT shows soft tissue swelling on right fronto- parietal region with both extra and intra 
cranial extensions (white star) along with the patch of destroyed bone (white arrow). 2b - CECT shows mild enhancement of mass 
(black star) and avid enhancement of its small intracranial extension (vertical black arrow). 2c - Bone window shows extracranial 
mass (white star) and intracranial destroyed fragment of bone (vertical up arrow) with clear transition zone (vertical down arrow).  
     
Figure 3 - MRI Head. 3a - T1W plain axial section shows extracranial non-homogenous iso-intense component (white star) with 
intracranial hypointense part (vertical up arrow) and many flow voids. 3b - T2W axial section shows iso to slight hyperintense mass 
(white star) with inhomogenous hypointense intracranial part (white down arrow). There is mass effect leading to midline shift 
(horizontal white arrow). Figure 4 - TOF MR angiography shows multiple draining veins at the interface of the mass (black star) 
and displacement of ACAs to the left side (white arrow). 
towards left frontal side. This was of extra axial in nature. 
There was destruction of underlying table with intracranial 
extension. Transition zone was very well demarcated. No 
calcification or ossifying matrix was noticed in the lesion 
except the fragment of destroyed bone (Figure 2 a, b, c). 
There was mild enhancement of the extra cranial 
component but intense enhancement of intracranial part 
leading to mild midline shift. MRI had further confirmed 
the contents almost resembling soft tissue. Post 
gadolinium enhancement was also noticed (Figure 3a & 
b). MR angiography showed extra cranial feeders with 
meshwork of draining veins (Figure 4). MR spectroscopy 
also has shown choline peak pointing towards the 
malignant nature (Figure 5). FNAC confirmed the 
diagnosis.  
The patient has been planned for emboliasation and 
excision. 
 
Figure 5 - MR Spectroscopy shows other peaks in addition to 
NAA pointing to the aggressive nature of the mass. 
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DISCUSSION 
Calvarial neoplasms account 0.8% of all the bone tumors. 
Cranial vault haemangiomas are less in frequency [2]. 
These do not produce any symptoms but the pressure and 
compression features can lead to secondary symptoms. 
These do not bleed. The bony involvement can best be 
demonstrated by CT. MRI is the best modality for their 
evaluation and extension [3]. MRI also shows better 
description of fatty hyper intense diploic space and the 
matrix of the lesion.  Various neurovascular structures in 
the adjoining region can be delineated for their 
involvement. T1W shows hyper intensity and T2W show 
heterogenous hyperintensity. These lesions show variable 
post contrast enhancement depending upon the underlying 
constituents and type of vascular malformation [4].  
Clinico-radiological-pathological diagnosis is essential 
part of these lesions. Lloret et al (2009) has reviewed the 
record of 61 cases of calvarial lesions and found the most 
common lesions were osteoma (26%), eosinophilic 
granuloma (18%), fibrous dysplasia (20%), osseous 
haemangioma (13%), epidermoids cysts (7%), 
miscellaneous benign lesions (8%) and osteosarcoma 
(8%). These did not include metastasis and multiple 
myeloma lesions [5]. It is very important to know the site 
of origin, size, number, pattern of bone destruction, 
margins, periosteal reaction, soft tissue component with 
extension and the type of matrix of the tumors. Aggressive 
tumors usually have poor zone of transition.  
Calvarial haemangiomas gives appearance of 
malignant tumors when extend both intracranially and 
extracranially. There is no periosteal reaction. MRI 
appearance shows serpentine vessels within the lesion and 
can be recognized easily [6]. In our case the giant tumor 
had both intracranial and extra cranial components with 
clear transition zone of skull table. Bone metastasis from 
few malignancies like renal cell carcinoma can present as 
multiple lytic lesions and can resemble cranial vault 
hemangiomas. These can either be osteoblastic or 
osteolytic in nature.  
Various options for the treatment are radiation therapy, 
pre operative embolisation, surgical resection or only 
intralesional ethanol injection [7]. The treatment decision 
depends upon the main complaints or aesthetic reasons. 
The mainstay of treatment remains as embolisation with 
excision of the mass in majority of the cases. Prognosis of 
the disease is excellent and recurrence is rare if total 
excision is made [8]. 
CONCLUSION 
Giant calvarial haemangioma do not show any symptoms 
for long time but keep on growing under the scalp. These 
extend to the intracranial compartment after destruction of 
the table. CT and MRI play a great role in the decision and 
roadmap of the management. The local aggressive role 
should not be confused with malignancy until or unless 
proved otherwise. Pre embolisation before surgical 
excision is of great benefit to avoid bleeding catastrophe. 
REFERENCES 
1. Kuzeyli K, Usul H, Cakir E, Caylan R, Rei A, Baykal S, 
et al. Multifocal intradiploic cavernous hemangioma of 
the skull associated with nasal osteoma. Acta Neurochir 
(Wien). 2003; 145: 323-326. 
2. Peterson DL, Murk SE, Story JL. Multifocal cavernous 
hemangioma of the skull: report of a case and review of 
the literature. Neurosurgery. 1992; 30: 778-781. 
3. Bastug D, Ortiz O, Schochet SS. Hemangiomas in the 
calvaria: imaging findings. AJR Am J Roentgenol. 1995; 
164: 683-687. 
4. Ortiz O, Schochet S, Bastug D. Imaging evaluation and 
clinicopathologic correlation of mass lesions involving the 
calvaria. Part I: congenital and traumatic lesions. Int J 
Neuroradiol. 1999; 5: 96-108. 
5. Lloret I, Server A, Taksdal I. Calvarial lesions: a 
radiological approach to diagnosis. Acta Radiol. 2009; 
50:531-542. 
6. Murphey MD, Fairbairn KJ, Parman LM, Baxter KG, Parsa 
MB, Smith WS. From the archives of the AFIP: 
Musculoskeltal angiomatous lesions: radiologic-
pathologic correlation. Radiographics. 1995; 15:893-917. 
7. Reis BL, Carvalho GT, Sousa AA et-al. Primary 
hemangioma of the skull. Arq Neuropsiquiatr. 2008; 66 
(3A):569-571. 
8. Relf SJ, Bartley GB, Unni KK. Primary orbital 
intraosseous hemangioma. Ophthalmology 1991. 98(4): -
541-6. 
 
How to cite this article: Sharma BB, Sharma S, Sarin M, 
Jilowa S, Kaur J. Giant Cranial Vault Frontal 
Haemangioma – A Case Report. Indian J Case Reports. 
2016; 2(2): 43-45. 
Conflict of interest: None stated, Funding: Nil 
